Crexont ER 87.5 MG-350 MG cap 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F63Z3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,261
Award facts
- Contract value 100% obligated
- $3,260.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Crexont ER (a pharmaceutical product available in 87.5 mg-350 mg capsules, quantity 120) with a ceiling value of $3,260.55. This firm fixed price delivery order, with an ultimate completion date of December 18, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical.
AmerisourceBergen Drug Corp maintains a comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the prime contract vehicle for this delivery order. The parent IDC provides a global pharmaceutical support platform enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a critical vendor within the federal medical procurement ecosystem, AmerisourceBergen demonstrates significant capability in fulfilling diverse pharmaceutical and medical supply requirements through competitively awarded contracts with DLA.
Quick answers
Who was awarded contract SPE2DR26F63Z3?
SPE2DR26F63Z3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F63Z3 worth?
The government has obligated $3,261 on SPE2DR26F63Z3.
Is contract SPE2DR26F63Z3 an order under another contract?
Yes. SPE2DR26F63Z3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63Z3 competed?
The extent of competition for SPE2DR26F63Z3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award